|
|||||
|
|
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. |
|
| Authors: | M Emerman M Guyader L Montagnier D Baltimore M A Muesing |
| Affiliation: | Unité d'Oncologie Viral (CNRS UA 1157), Institut Pasteur, Paris, France. |
| Abstract: | |
| Keywords: | |